Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Estimating the number of diseases – the concept of rare, ultra-rare, and hyper-rare
Smith Rjh, Peter Bergman, Daniel W. Hagey
iScience (2022) Vol. 25, Iss. 8, pp. 104698-104698
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Unlocking life-threatening COVID-19 through two types of inborn errors of type I IFNs
Jean‐Laurent Casanova, Mark S. Anderson
Journal of Clinical Investigation (2023) Vol. 133, Iss. 3
Open Access | Times Cited: 45
A generalist medical language model for disease diagnosis assistance
Xiaohong Liu, Hao Liu, Guoxing Yang, et al.
Nature Medicine (2025)
Closed Access | Times Cited: 3
Breast Implants and the Risk of Squamous Cell Carcinoma of the Breast: A Systematic Literature Review and Epidemiologic Study
Fabio Santanelli di Pompeo, Guido Firmani, Emilia Stanzani, et al.
Aesthetic Surgery Journal (2024) Vol. 44, Iss. 7, pp. 757-768
Closed Access | Times Cited: 11
Enhancing pediatric access to cell and gene therapies
Crystal L. Mackall, Catherine M. Bollard, Nancy L. Goodman, et al.
Nature Medicine (2024) Vol. 30, Iss. 7, pp. 1836-1846
Closed Access | Times Cited: 10
Emergence of the natural history of Myhre syndrome: 47 patients evaluated in the Massachusetts General Hospital Myhre Syndrome Clinic (2016–2023)
Angela E. Lin, Eleanor R. Scimone, Robyn P. Thom, et al.
American Journal of Medical Genetics Part A (2024) Vol. 194, Iss. 10
Open Access | Times Cited: 8
Precision medicine in rare diseases: What is next?
Bianca Tesi, Cathérine Boileau, Kym M. Boycott, et al.
Journal of Internal Medicine (2023) Vol. 294, Iss. 4, pp. 397-412
Open Access | Times Cited: 17
Cryo-electron microscopy-based drug design
Ecenur Cebi, Joohyun Lee, Vinod Kumar Subramani, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 5
A Systematic Review of the Epidemiology and Disease Burden of Congenital and Immune-Mediated Thrombotic Thrombocytopenic Purpura
Ping Du, Tiffany Cristarella, Camille Goyer, et al.
Journal of Blood Medicine (2024) Vol. Volume 15, pp. 363-386
Open Access | Times Cited: 5
The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmap
Anneliene Hechtelt Jonker, Elena-Alexandra Tãtaru, Holm Graeßner, et al.
Nature Reviews Drug Discovery (2024) Vol. 24, Iss. 1, pp. 40-56
Closed Access | Times Cited: 5
Advances in bio-polymer coatings for probiotic microencapsulation: chitosan and beyond for enhanced stability and controlled release
Great Iruoghene Edo, Alice Njolke Mafe, Nawar. F. Razooqi, et al.
Designed Monomers & Polymers (2024) Vol. 28, Iss. 1, pp. 1-34
Open Access | Times Cited: 5
Rare Disease Narratives on Social Media: A Content Analysis
H Park, Cassidy Scott, Hadley Stevens Smith, et al.
Genetics in Medicine Open (2025) Vol. 3, pp. 102844-102844
Open Access
Rare genetic diseases in India: Steps toward a nationwide mission program
Anjana Kar, Pandarisamy Sundaravadivel, Ashwin Dalal
Journal of Biosciences (2024) Vol. 49, Iss. 1
Closed Access | Times Cited: 4
Evidence for common mechanisms of pathology between SHANK3 and other genes of Phelan‐McDermid syndrome
Andrew R. Mitz, Luigi Boccuto, Audrey Thurm
Clinical Genetics (2024) Vol. 105, Iss. 5, pp. 459-469
Open Access | Times Cited: 4
Invisible patients in rare diseases: parental experiences with the healthcare and social services for children with rare diseases. A mixed method study
Jan Domaradzki, Dariusz Walkowiak
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
The application of the facial analysis program Face2Gene in a single genetic counseling center: a retrospective study
Dinnar Yahya, Milena Stoyanova, Mari Hachmeriyan, et al.
Egyptian Pediatric Association Gazette (2025) Vol. 73, Iss. 1
Open Access
Telemedicine for Personalized Nutritional Intervention of Rare Diseases: A Narrative Review on Approaches, Impact, and Future Perspectives
Francesca Eletti, Veronica Maria Tagi, I. Greco, et al.
Nutrients (2025) Vol. 17, Iss. 3, pp. 455-455
Open Access
Comparative valuation of longstanding and novel treatments for sickle cell disease: a multinational MCDA study
Khadidja Abdallah, Isabelle Huys, Kathleen Claes, et al.
Discover Health Systems (2025) Vol. 4, Iss. 1
Open Access
Challenges and Possible Strategies to Address Them in Rare Disease Drug Development: A Statistical Perspective
Jie Chen, Lei Nie, Shiowjen Lee, et al.
Clinical Pharmacology & Therapeutics (2025)
Open Access
Drug development for neglected ultra-rare diseases of no commercial interest: Challenges and opportunities
Joseph A Katakowski, Juan C. López
Drug Discovery Today (2025), pp. 104346-104346
Open Access
The Magic of Proteases: From a Procoagulant and Anticoagulant Factor V to an Equitable Treatment of Its Inherited Deficiency
Juan A. De Pablo-Moreno, Andrea Miguel-Batuecas, María de Sancha, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6243-6243
Open Access | Times Cited: 10
Decentralisation in Clinical Trials and Patient Centricity: Benefits and Challenges
Shubhadeep Sinha, Sreenivasa Chary Sriramadasu, Ruby Raphael, et al.
Pharmaceutical Medicine (2024) Vol. 38, Iss. 2, pp. 109-120
Closed Access | Times Cited: 3
Unlocking the full potential of rare disease drug development: exploring the not-for-profit sector’s contributions to drug development and access
Stefano Vavassori, Sean Russell, Celeste Scotti, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Caregiver-Reported Economic Impacts of Pediatric Rare Diseases—A Scoping Review
Niamh Buckle, Orla Doyle, Naonori Kodate, et al.
Healthcare (2024) Vol. 12, Iss. 24, pp. 2578-2578
Open Access | Times Cited: 2
Development of Essential Oil Delivery Systems by ‘Click Chemistry’ Methods: Possible Ways to Manage Duchenne Muscular Dystrophy
Greta Kaspute, Bharani Dharan Arunagiri, Rakshana Alexander, et al.
Materials (2023) Vol. 16, Iss. 19, pp. 6537-6537
Open Access | Times Cited: 6
Digital health and Clinical Patient Management System (CPMS) platform utility for data sharing of neuromuscular patients: the Italian EURO-NMD experience
F. Fortunato, Francesca Bianchi, Giulia Ricci, et al.
Orphanet Journal of Rare Diseases (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top